Excessively increased CSF tau in progressive multifocal leukoencephalopathy

Clinical Neurology and Neurosurgery

Volumn 114, Issue 6, 2012, Pages 762-764

  Brüggemann, Norbert ^a   Gottschalk, Stefan ^a   Körtke, Detlev ^a   Marxsen, Jan H ^a   Moser, Andreas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Biomarker; CSF; Progressive multifocal leukoencephalopathy; Rituximab; Tau

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[1-42]; BENDAMUSTINE; IMMUNOGLOBULIN G; MEFLOQUINE; RITUXIMAB; TAU PROTEIN; VINCRISTINE;

AGED; ARTICLE; B CELL LYMPHOMA; BLOOD CEREBROSPINAL FLUID BARRIER; BRADYKINESIA; BRAIN ATROPHY; BRAIN HEMORRHAGE; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; DRUG WITHDRAWAL; DYSARTHRIA; DYSPHAGIA; GAIT DISORDER; HUMAN; LUMBAR PUNCTURE; MAINTENANCE THERAPY; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POLYNEUROPATHY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; URINE INCONTINENCE; VIRUS ENTRY; VIRUS REPLICATION;

AGED; AMYLOID BETA-PEPTIDES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ATROPHY; BRAIN; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, B-CELL; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84862000572     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2011.12.032     Document Type: Article

References (10)

1. F. Deisenhammer, R. Egg, G. Giovannoni, B. Hemmer, A. Petzold, and F. Sellebjerg EFNS guidelines on disease-specific CSF investigations Eur J Neurol 16 2009 760 770
2. M. Ost, K. Nylen, L. Csajbok, A.O. Ohrfelt, M. Tullberg, and C. Wikkelso Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury Neurology 67 2006 1600 1604
3. J.R. Berger Progressive multifocal leukoencephalopathy Curr Neurol Neurosci Rep 7 2007 461 469
4. A. De Luca, A. Ammassari, A. Cingolani, M.L. Giancola, and A. Antinori Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy AIDS 12 1998 1937 1938
5. J.R. Berger, S.A. Houff, and E.O. Major Monoclonal antibodies and progressive multifocal leukoencephalopathy MAbs 1 2009 583 589
6. A.J. Green, G. Giovannoni, M.A. Hall-Craggs, E.J. Thompson, and R.F. Miller Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease Sex Transm Infect 76 2000 443 446
7. M. Brickelmaier, A. Lugovskoy, R. Kartikeyan, M.M. Reviriego-Mendoza, N. Allaire, and K. Simon Identification and characterization of mefloquine efficacy against JC virus in vitro Antimicrob Agents Chemother 53 2009 1840 1849
8. C. Hesse, L. Rosengren, E. Vanmechelen, H. Vanderstichele, C. Jensen, and P. Davidsson Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke J Alzheimers Dis 2 2000 199 206
9. D. Yuksel, D. Yilmaz, N.Y. Uyar, N. Senbil, Y. Gurer, and B. Anlar Tau proteins in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis Brain Dev 2009
10. N. Shahani, and R. Brandt Functions and malfunctions of the tau proteins Cell Mol Life Sci 59 2002 1668 1680